[ad_1]
Investing.com – PDS Biotech reported on Monday third quarter that beat analysts’ forecasts and income that was inline with expectations.
PDS Biotech introduced earnings per share of $-0.26 on income of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.28 on income of $0.
PDS Biotech shares are down 89% from the start of the yr and are buying and selling at $7.34 , down-from-52-week-high.
PDS Biotech shares gained 31.07% in intra-day commerce the report.
PDS Biotech follows different main Healthcare sector earnings this month
PDS Biotech’s report follows an earnings beat by J&J on Tuesday, October 18, 2022, who reported EPS of $2.55 on income of $23.79B, in comparison with forecasts EPS of $2.48 on income of $23.36B.
Eli Lilly had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.98 on income of $6.94B, in comparison with forecast for EPS of $1.91 on income of $6.91B.
Keep up-to-date on all the upcoming earnings reviews by visiting Investing.com’s earnings calendar
[ad_2]
Source link